Guardion Health Sciences, Inc. (NASDAQ:GHSI – Get Free Report) declared a dividend on Wednesday, August 21st, Zacks reports. Stockholders of record on Monday, September 9th will be given a dividend of 5.00 per share on Monday, September 23rd. The ex-dividend date is Tuesday, September 24th.
Guardion Health Sciences Stock Up 0.7 %
GHSI stock opened at $10.93 on Monday. Guardion Health Sciences has a twelve month low of $5.01 and a twelve month high of $18.00. The firm has a market cap of $14.03 million, a price-to-earnings ratio of -2.72 and a beta of 0.80. The business’s fifty day simple moving average is $10.62 and its two-hundred day simple moving average is $9.53.
Guardion Health Sciences (NASDAQ:GHSI – Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported ($1.64) EPS for the quarter. The company had revenue of $0.07 million during the quarter. Guardion Health Sciences had a negative return on equity of 73.69% and a net margin of 22.79%.
Guardion Health Sciences Company Profile
Guardion Health Sciences, Inc, a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment.
See Also
- Five stocks we like better than Guardion Health Sciences
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- See Why Oracle’s Cloud Infrastructure Growth Demands Attention
- Bank Stocks – Best Bank Stocks to Invest In
- Darden Restaurants Is on the Verge of a Significant Breakout
- The How And Why of Investing in Oil Stocks
- Onsemi Could Be Set Up For a Solid Rebound: Here’s Why
Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.